NATCOPHARM.NS vs. RDY
Compare and contrast key facts about Natco Pharma Limited (NATCOPHARM.NS) and Dr. Reddy's Laboratories Limited (RDY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NATCOPHARM.NS or RDY.
Correlation
The correlation between NATCOPHARM.NS and RDY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NATCOPHARM.NS vs. RDY - Performance Comparison
Key characteristics
NATCOPHARM.NS:
-0.56
RDY:
-0.24
NATCOPHARM.NS:
-0.55
RDY:
-0.19
NATCOPHARM.NS:
0.92
RDY:
0.98
NATCOPHARM.NS:
-0.44
RDY:
-0.26
NATCOPHARM.NS:
-1.73
RDY:
-0.59
NATCOPHARM.NS:
12.85%
RDY:
9.22%
NATCOPHARM.NS:
39.76%
RDY:
22.30%
NATCOPHARM.NS:
-89.98%
RDY:
-58.55%
NATCOPHARM.NS:
-50.07%
RDY:
-20.20%
Fundamentals
NATCOPHARM.NS:
₹145.63B
RDY:
$11.17B
NATCOPHARM.NS:
₹104.15
RDY:
$0.74
NATCOPHARM.NS:
7.81
RDY:
18.07
NATCOPHARM.NS:
₹42.77B
RDY:
$317.20B
NATCOPHARM.NS:
₹33.10B
RDY:
$189.51B
NATCOPHARM.NS:
₹24.75B
RDY:
$69.94B
Returns By Period
In the year-to-date period, NATCOPHARM.NS achieves a -42.73% return, which is significantly lower than RDY's -14.88% return. Over the past 10 years, NATCOPHARM.NS has outperformed RDY with an annualized return of 12.30%, while RDY has yielded a comparatively lower 4.39% annualized return.
NATCOPHARM.NS
-42.73%
-36.08%
-48.63%
-22.08%
4.63%
12.30%
RDY
-14.88%
-9.19%
-18.65%
-5.66%
11.93%
4.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NATCOPHARM.NS vs. RDY — Risk-Adjusted Performance Rank
NATCOPHARM.NS
RDY
NATCOPHARM.NS vs. RDY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Natco Pharma Limited (NATCOPHARM.NS) and Dr. Reddy's Laboratories Limited (RDY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NATCOPHARM.NS vs. RDY - Dividend Comparison
NATCOPHARM.NS's dividend yield for the trailing twelve months is around 0.91%, less than RDY's 7.13% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NATCOPHARM.NS Natco Pharma Limited | 0.91% | 0.41% | 1.17% | 1.11% | 0.39% | 0.91% | 1.18% | 1.25% | 0.75% | 0.35% | 0.17% | 0.33% |
RDY Dr. Reddy's Laboratories Limited | 7.13% | 6.07% | 4.21% | 1.48% | 2.61% | 2.31% | 3.54% | 3.94% | 4.13% | 0.66% | 3.37% | 3.00% |
Drawdowns
NATCOPHARM.NS vs. RDY - Drawdown Comparison
The maximum NATCOPHARM.NS drawdown since its inception was -89.98%, which is greater than RDY's maximum drawdown of -58.55%. Use the drawdown chart below to compare losses from any high point for NATCOPHARM.NS and RDY. For additional features, visit the drawdowns tool.
Volatility
NATCOPHARM.NS vs. RDY - Volatility Comparison
Natco Pharma Limited (NATCOPHARM.NS) has a higher volatility of 26.19% compared to Dr. Reddy's Laboratories Limited (RDY) at 5.66%. This indicates that NATCOPHARM.NS's price experiences larger fluctuations and is considered to be riskier than RDY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NATCOPHARM.NS vs. RDY - Financials Comparison
This section allows you to compare key financial metrics between Natco Pharma Limited and Dr. Reddy's Laboratories Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities